Newest studies
Every summary in our library, newest first, as a dated timeline.
Showing 1,026–1,050 of 27,380 studies, newest first · page 42 of 1096.
July 2026 14
-
2026-07-01
ENHANCED ALZHEIMER DISEASE DIAGNOSIS THROUGH DEEP LEARNING-BASED MRI SEGMENTATION AND CLASSIFICATION
26/100 ✓ Peer-reviewed Brain scans and imaging RCHUB JOURNAL OF COMPUTATIONAL INTELLIGENCE SCIENCE AND ENGINEERING (JCISE)
Key finding: MRI has become an effective modality for analyzing the brain structure, which offers a detailed insights into the pathological regions that is associated with the AD. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2026-07-01
Amyloid probability in Alzheimer disease from plasma, cerebrospinal fluid, and amyloid imaging
36/100 ✓ Peer-reviewed Brain scans and imaging npj Dementia
Key finding: Blood-based biomarkers are increasingly used to triage patients for amyloid confirmation, yet performance is often reported versus a single comparator despite discordance between amyloid PET and CSF.
Full summary, score breakdown and related studies → Original source
-
2026-07-01
Towards an Equitable Approach to Multilingual Language Assessment in Dementia Care
33/100 ✓ Peer-reviewed Getting a diagnosis Topics in Language Disorders
Key finding: Health disparities in dementia care are amplified among aging multilingual communities relative to their monolingual English-speaking counterparts, as social determinants of health and significant gaps in culturally responsive practice can contribute to misdiagnosis, underdiagnosis, and delays in intervention. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2026-07-01
CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk
37/100 ✓ Peer-reviewed Genetics DOAJ (DOAJ: Directory of Open Access Journals)
Key finding: We show that CD33M ectodomain dimerizes, enabling binding of large multi-sialylated molecules.
Full summary, score breakdown and related studies → Original source
-
2026-07-01
Recent breakthroughs in blood-based biomarkers of Alzheimer disease: opportunities and challenges in older adults
36/100 ✓ Peer-reviewed Biomarkers Age and Ageing
Key finding: Across multiple analytical platforms, plasma p-tau217 has demonstrated consistently strong diagnostic performance for the detection of amyloid pathology. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2026-07-01
Loneliness Moderates the Association between Neighborhood Disadvantage and Cognitive Function Among Older Adults
41/100 ✓ Peer-reviewed Risk factors Delaware Journal of Public Health
Key finding: Loneliness moderated the relationship between national ADI scores and short-term visuospatial memory. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-07-01
[Consistency evaluation of the domestic Lifotronic platform and foreign luminescence platforms in detecting core cerebrospinal fluid biomarkers in Chinese Alzheimer disease patients]
43/100 ✓ Peer-reviewed Tau biomarkers Zhonghua yi xue za zhi
Key finding: CSF samples were retrospectively collected from 253 subjects recruited at Peking Union Medical College Hospital, Xuanwu Hospital Capital Medical University, and Beijing Tiantan Hospital between July 2013 and September 2019. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2026-07-01
Plasma Phosphorylated Tau 217 in Participants at Risk for Chronic Traumatic Encephalopathy
52/100 ✓ Peer-reviewed Tau biomarkers JAMA network open
Key finding: In vivo biomarkers for detecting neuropathologies from repetitive head impacts (RHI), including chronic traumatic encephalopathy (CTE), are needed. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2026-07-01
Early Alzheimer´s disease blood biomarkers are associated with a higher risk for postoperative long-term cognitive decline: Insights from the FINDERI study
49/100 ✓ Peer-reviewed Tau biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association
Key finding: The study aim is to investigate whether blood biomarkers (BBMs) of Alzheimer's disease (AD) pathology are associated with postoperative cognitive dysfunction (POCD) after cardiac surgery. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2026-07-01
Lecanemab in symptomatic PSEN1 p.Met233Val early-onset Alzheimer's disease: Neuroimaging safety, regional amyloid-PET dynamics, and longitudinal plasma biomarkers
46/100 ✓ Peer-reviewed Tau biomarkers Alzheimer's & dementia (Amsterdam, Netherlands)
Key finding: No amyloid-related imaging abnormalities occurred. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2026-07-01
The tau biomarker cascade is condensed in Down syndrome compared with sporadic Alzheimer's disease
56/100 ✓ Peer-reviewed Down syndrome and Alzheimer's Brain : a journal of neurology
Key finding: Individuals with DS had a significantly higher lifetime risk of beta-amyloid plaque onset. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2026-07-01
Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer Disease
68/100 ✓ Peer-reviewed Biomarkers JAMA Neurology
Key finding: The BioFINDER-2 main cohort included 872 participants, with an additional 156 participants in the Knight ADRC cohort for independent validation. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2026-07 month only
APOE-ε4 carriership and dementia risk over 10 years among Asian American and White older adults
55/100 ✓ Peer-reviewed Genetics Alzheimer's & Dementia
Key finding: Despite differences in prevalence of APOE-ε4, its association with dementia risk was similar across Chinese, Japanese, Filipino, and non-Latino White participants. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2026-07-01
Genetic Risk for Alzheimer Disease, Midlife Hypertension, and Dementia: The ARIC Neurocognitive Study
58/100 ✓ Peer-reviewed Genetics Neurology
Key finding: Genetic risk for AD does not modify the association between hypertension and dementia. +3 more findings
Full summary, score breakdown and related studies → Original source
June 2026 11
-
2026-06-30
Functional–behavioral patterns associated with care-related risk in hospitalized patients with Alzheimer’s disease: a real-world clustering analysis
16/100 ⚠ Preprint — not yet peer-reviewed Clinical safety Research Square
Key finding: Functional–behavioral subtypes can be identified in hospitalized AD patients, supporting multidimensional risk stratification and individualized care planning. +1 more finding
Scored 35 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-06-30
How and why adult day programs influence admissions to long-term care homes for persons living with dementia: A program theory based on a realist review
16/100 ⚠ Preprint — not yet peer-reviewed Health systems and care delivery Research Square
Key finding: Contexts and mechanisms associated with attendees’ and caregivers’ social determinants of health, and system-level contexts and mechanisms that influence ADPs are important knowledge gaps to be addressed by studies and to be incorporated in our program theory in the future. +2 more findings
Scored 27 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-06-30
Neuroinflammation and Tauopathies
45/100 ✓ Peer-reviewed Inflammation and the immune system Molecular biology reports
Key finding: This review combines current knowledge on the molecular and cellular mechanisms linking Tau pathology to chronic neuroinflammatory signaling, with a particular focus on microglia- and astrocyte-mediated responses. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-06-30
The Silent Crisis: Loneliness in Older Adults-A Critical Review of Impacts, Strategies and Path Forward
46/100 ✓ Peer-reviewed Health systems and care delivery Scandinavian journal of caring sciences
Key finding: Mechanisms include increased inflammation (↑CRP, IL-6), HPA dysregulation, immune compromise, hippocampal atrophy, and behavioural lapses. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-06-30
Exossomos, Neuroinflamação e Biomarcadores Hematológicos na Doença de Alzheimer: revisão Sistemática
36/100 ✓ Peer-reviewed Tau biomarkers Revista Educação em Saúde/Revista Educação em Saúde Unievangélica
Key finding: Foram incluídos artigos originais e revisões publicados nos últimos 10 anos, em inglês, português ou espanhol, relacionados a exossomos neuronais, biomarcadores hematológicos, neuroinflamação e nanotecnologia aplicada à DA. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-06-30
Therapeutic monoclonal antibodies targeting amyloid beta in Alzheimer disease current evidence clinical outcomes limitations and future directions
31/100 ✓ Peer-reviewed Treatments Discover Neuroscience
Key finding: Recent regulatory approvals of aducanumab, lecanemab, and donanemab demonstrate significant plaque reduction and modest slowing of cognitive decline in early AD, supporting the amyloid hypothesis.
Full summary, score breakdown and related studies → Original source
-
2026-06-30
PET Imaging in Alzheimer Disease: Diagnostic and Prognostic Applications
29/100 ✓ Peer-reviewed Biomarkers International Journal of Clinical and Medical Research
Key finding: Evidence indicates that amyloid PET is highly useful for establishing amyloid pathology, whereas tau PET is more closely associated with disease stage and clinical severity.
Full summary, score breakdown and related studies → Original source
-
2026-06-29
Transitional care needs of persons with dementia and their care partners: a secondary analysis using Transitions Theory
16/100 ⚠ Preprint — not yet peer-reviewed End-of-life care medRxiv
Key finding: When tailored transitional care guidance is lacking, care partners must take on significant responsibility for finding information and making decisions.
Scored 27 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-06-29
Anti-amyloid immunotherapy drives APOE4 specific increases in glial reactivity, perivascular immune activation, and ARIA-like events
16/100 ⚠ Preprint — not yet peer-reviewed Treatments bioRxiv
Key finding: E4FAD mice demonstrated plaque reductions with accompanying increases in microhemorrhages (measured on both MRI and histology), and increases in microglial and astrocyte reactivity - especially in the perivascular compartment. +2 more findings
Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-06-29
Oral Microbiome and Its Emerging Role in Alzheimer\'s Disease: A Comprehensive Review
36/100 ✓ Peer-reviewed Treatments Journal of Acute Care Trauma and Emergency Medicine
Key finding: Alzheimer's disease (AD) affects ~55 million people globally and is projected to rise steeply with population ageing.
Full summary, score breakdown and related studies → Original source
-
2026-06-29
Prior Traumatic Brain Injury and Alzheimer Disease Blood Biomarkers
58/100 ✓ Peer-reviewed Biomarkers JAMA Neurology
Key finding: In 272 participants, mean (SD) age was 70 (4.5) years, 270 were male (99.3%), and 83 (30.5%) were amyloid-PET positive. +4 more findings
Full summary, score breakdown and related studies → Original source
Browse the library by subject, with the full score breakdown →